Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Flat Capital AB (publ) in connection with its listing on Nasdaq First North Growth Market
Mandate

Vinge has advised Flat Capital AB (publ) in connection with its listing on Nasdaq First North Growth Market

October 20, 2021 Capital Markets and Public M&A

Vinge has advised Flat Capital AB (publ) (“Flat Capital” or the “Company”) in connection with its listing on Nasdaq First North Growth Market. The prospectus was published on 29 September 2021 and the first day of trading on Nasdaq First North Growth Market was 20 October 2021.

Flat Capital is an investment company founded by Nina and Sebastian Siemiatkowski that focuses on companies with prominent entrepreneurs in leading positions. The company aims to contribute long-term capital to entrepreneur-led companies that may otherwise be dependent on investors with shorter time horizons. The largest investments are Klarna Holding AB, Budbee AB and True Software Scandinavia AB (Truecaller).


Vinge’s team consisted of Jesper Schönbeck, Joel Wahlberg, Anna Grigorian and Anna Svensson.

 

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026